Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | 3 | VEGF | 1000.0 | 75 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | VEGF | 1199.5 | 52 | ||||
N2759 | 3 | VEGF | 1051.5 | 72 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | VEGF | 1033.0 | 54 | ||||
RA1931 | 3 | VEGF | 1315.0 | 61 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | VEGF | 1279.0 | 72 | ||||
N2586 | 3 | VEGF | 1114.0 | 60 | |||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 666.0 | 85 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 757.0 | 57 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 943.0 | 64 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 998.0 | 54 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1004.0 | 59 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1051.0 | 62 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1067.0 | 67 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1106.0 | 83 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1227.0 | 67 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1275.0 | 77 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1285.0 | 69 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1233.5 | 76 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1429.0 | 67 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1282.5 | 60 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1774.0 | 61 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | VEGF | 1567.5 | 50 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 548.0 | 107 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | VEGF | 751.0 | 77 |